Back to the main directory
EarningsReview / Equity
- Cholamandalam Investment (CIFC IN) by HSBC
- No Quick Fix + 10 Q''s by BNP Paribas Exane
- European IRA response: More questions than answers by BNP Paribas Exane
- Novo Nordisk (Buy, TP: DKK1130.00) - Wide 2023 guidance by DnB Markets
- Nykode Therapeutics (Buy, TP: NOK102.00) - Three key positives by DnB Markets
- Frontline (Buy, TP: NOK200.00) - Premium stock at a discount by DnB Markets
- Arctic Fish (Buy, TP: NOK135.00) - 2023e set to be transformative by DnB Markets
- Ossur (Buy, TP: DKK39.00) - Soft but improving 2023 outlook by DnB Markets
- DHT Holdings (Buy, TP: USD11.40) - Cashing in on earnings capacity by DnB Markets
- Beijer Ref (Hold, TP: SEK175.00) - Growth on track by DnB Markets
- Getinge (Hold, TP: SEK245.00) - 2023 set to be back-end loaded by DnB Markets
- Novo Nordisk (Buy, TP: DKK1130.00) - Wegovy key for wide guidance by DnB Markets
- Moneysupermarket Group (MONY LN) by HSBC
- Ringkjøbing Landbobank - The curse of lofty consensus expectations by Danske Bank Equity Research
- Upgrading sector estimates on China re-opening by BNP Paribas Exane
- Tales Of An Inventory Overhang - Read Through To SWKS by BNP Paribas Exane
- Growth ambitions remain expensive by BNP Paribas Exane
- Ringkjoebing Landbobank - Buy/DKK 1,120: A good buying opportunity by Nordea
- Oersted - Buy/DKK 950 (1,000): Lower IRR assumptions but still plenty of value by Nordea
- Getinge - Buy/SEK 275 (260): The recovery play remaining attractive by Nordea
- Novo Nordisk - Buy/DKK 1,050 (1,020): GLP-1 pedal to the metal by Nordea
- Novo Nordisk - Wegovy takes off by Danske Bank Equity Research
- Investment Daily 02/02/2023 by BNP Paribas Exane
- 4iG - Completion of Vodafone Hungary acquisition by Edison Investment Research
- Paradigm Biopharma - Funded past near-term inflection points by Edison Investment Research
- A good capital print and realistic guidance by BNP Paribas Exane
- FY22 preview: where to focus at upcoming results by BNP Paribas Exane
- Axfood (Hold, TP: SEK295.00) - Margins spoil the fun by DnB Markets
- Norwegian Air Shuttle (Buy, TP: NOK9.00) - Flyr files for bankruptcy by DnB Markets
- Stora Enso (Buy, TP: EUR18.00) - Headwinds and tailwinds by DnB Markets
- Electrolux Professional (Hold, TP: SEK50.00) - Still-solid demand by DnB Markets
- Tele2 (Buy, TP: SEK110.00) - FCF issue a short-term headache by DnB Markets
- Ncc (Buy, TP: SEK125.00) - Mixed Q4 by DnB Markets
- Teekay Tankers (Buy, TP: USD47.10) - 75% upside potential to 1.0x NAV by DnB Markets
- Epiroc (Hold, TP: SEK220.00) - Fairly valued structural growth story by DnB Markets
- Husqvarna (Sell, TP: SEK82.00) - Everything everywhere all at once by DnB Markets
- Keeling, not healing by BNP Paribas Exane
- Indian Hotels (IH IN) by HSBC
- Facing a UK consumer crunch by BNP Paribas Exane
- 1Q23 beat and raise. 2023: MandA, Women''s Health focus by BNP Paribas Exane
- U.S. Auto SAAR: Solid Start to the Year, Seasonality Factor Says Amazing by BNP Paribas Exane
- Vitec Software Group - Buy/SEK 520 (457): Case confirmed by Nordea
- Husqvarna - Sell/SEK 80 (Hold): Down to Sell after recent good performance by Nordea
- Axfood - Sell/SEK 215 (Hold): Tailwinds turning to headwinds by Nordea
- Lagercrantz - Hold: Solid as a rock by Nordea
- Some succour by BNP Paribas Exane
- Cranswick (CWK LN) by HSBC
- EQUITA SIM: OVS (HOLD; Unchanged) - Company Update by Equita Sim
- Pan American Silver - Shareholders approve Yamana transaction by Edison Investment Research
- SANTANDER: RDOS. 4T’22 (ANÁLISIS BANCO SABADELL) by Sabadell